A Novel Simple Assay System to Quantify the Percent HCV-RNA Levels of NS5A Y93H Mutant Strains and Y93 Wild-Type Strains Relative to the Total HCV-RNA Levels to Determine the Indication for Antiviral Therapy with NS5A Inhibitors-Reference-Cited by-同舟云学术

A Novel Simple Assay System to Quantify the Percent HCV-RNA Levels of NS5A Y93H Mutant Strains and Y93 Wild-Type Strains Relative to the Total HCV-RNA Levels to Determine the Indication for Antiviral Therapy with NS5A Inhibitors

Published:2014-11-14 Issue:11 Volume:9 Page:e112647
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Uchida Yoshihito,Kouyama Jun-ichi,Naiki Kayoko,Mochida Satoshi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference22 articles.

1. Global epidemiology of hepatitis C virus infection: New estimate of age-specific antibody to HCV seroprevalence;K Mohd Hanafiah;Hepatology,2013

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;HB El-Serag;Gastroenterology,2012

3. World Health Organization Hepatitis C, Fact sheet N164, Updated June 2013. Available: http://www.who.int/mediacentre/factsheets/fs164/en/index.html. Accessed 2014 Oct 25.

4. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan;I Ikai;Hepatol Res,2007

5. Epidemiology of hepatocellular carcinoma in Japan;T Umemura;J Gastroenterol,2009

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection;Health Science Reports;2022-01

2. EFFICACY OF SOFOSBUVIR AND DACLATASVIR IN COMPENSATED CHRONIC HEPATITIS C INFECTION: A SINGLE CENTER, OPEN-LABEL AND PROOF OF CONCEPT STUDY;GLOBAL JOURNAL FOR RESEARCH ANALYSIS;2021-03-15

3. Efficacy and safety of glecaprevir/pibrentasvir in patients with hepatitis C virus infection aged ≥75 years;Geriatrics & Gerontology International;2020-04-08

4. Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus;Hepatology Research;2020-04

5. Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all‐oral direct antiviral therapy;Hepatology Research;2020-04